The global Recombinant Proteins market was valued at US$ 1004 million in 2022 and is projected to reach US$ 2284.2 million by 2029, at a CAGR of 12.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins. This report contains market size and forecasts of Recombinant Proteins in global, including the following market information:
Global Recombinant Proteins Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Proteins companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Proteins Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Proteins Market Segment Percentages, by Type, 2022 (%)
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Global Recombinant Proteins Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Proteins Market Segment Percentages, by Application, 2022 (%)
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Global Recombinant Proteins Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Recombinant Proteins Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Proteins revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Recombinant Proteins revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Proteins, market overview.
Chapter 2: Global Recombinant Proteins market size in revenue.
Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Recombinant Proteins Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Proteins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Proteins Overall Market Size
2.1 Global Recombinant Proteins Market Size: 2022 VS 2029
2.2 Global Recombinant Proteins Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Proteins Players in Global Market
3.2 Top Global Recombinant Proteins Companies Ranked by Revenue
3.3 Global Recombinant Proteins Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Proteins Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Proteins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Proteins Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Proteins Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Proteins Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Proteins Market Size Markets, 2022 & 2029
4.1.2 Hormones
4.1.3 Growth Factors
4.1.4 Cytokines
4.1.5 Plasma Protein Factor
4.1.6 Recombinant Metabolic Enzymes
4.1.7 Immune Checkpoint Regulators
4.1.8 Others
4.2 By Type - Global Recombinant Proteins Revenue & Forecasts
4.2.1 By Type - Global Recombinant Proteins Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Proteins Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Proteins Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Proteins Market Size, 2022 & 2029
5.1.2 Biopharmaceutical Companies
5.1.3 Academic and Research Institutes
5.1.4 Contract Research Organizations
5.2 By Application - Global Recombinant Proteins Revenue & Forecasts
5.2.1 By Application - Global Recombinant Proteins Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Proteins Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Proteins Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Proteins Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Proteins Revenue & Forecasts
6.2.1 By Region - Global Recombinant Proteins Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Proteins Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Proteins Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Recombinant Proteins Revenue, 2018-2029
6.3.2 US Recombinant Proteins Market Size, 2018-2029
6.3.3 Canada Recombinant Proteins Market Size, 2018-2029
6.3.4 Mexico Recombinant Proteins Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Recombinant Proteins Revenue, 2018-2029
6.4.2 Germany Recombinant Proteins Market Size, 2018-2029
6.4.3 France Recombinant Proteins Market Size, 2018-2029
6.4.4 U.K. Recombinant Proteins Market Size, 2018-2029
6.4.5 Italy Recombinant Proteins Market Size, 2018-2029
6.4.6 Russia Recombinant Proteins Market Size, 2018-2029
6.4.7 Nordic Countries Recombinant Proteins Market Size, 2018-2029
6.4.8 Benelux Recombinant Proteins Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Recombinant Proteins Revenue, 2018-2029
6.5.2 China Recombinant Proteins Market Size, 2018-2029
6.5.3 Japan Recombinant Proteins Market Size, 2018-2029
6.5.4 South Korea Recombinant Proteins Market Size, 2018-2029
6.5.5 Southeast Asia Recombinant Proteins Market Size, 2018-2029
6.5.6 India Recombinant Proteins Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Recombinant Proteins Revenue, 2018-2029
6.6.2 Brazil Recombinant Proteins Market Size, 2018-2029
6.6.3 Argentina Recombinant Proteins Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Proteins Revenue, 2018-2029
6.7.2 Turkey Recombinant Proteins Market Size, 2018-2029
6.7.3 Israel Recombinant Proteins Market Size, 2018-2029
6.7.4 Saudi Arabia Recombinant Proteins Market Size, 2018-2029
6.7.5 UAE Recombinant Proteins Market Size, 2018-2029
7 Recombinant Proteins Companies Profiles
7.1 Bio-Techne Corporation
7.1.1 Bio-Techne Corporation Company Summary
7.1.2 Bio-Techne Corporation Business Overview
7.1.3 Bio-Techne Corporation Recombinant Proteins Major Product Offerings
7.1.4 Bio-Techne Corporation Recombinant Proteins Revenue in Global Market (2018-2023)
7.1.5 Bio-Techne Corporation Key News & Latest Developments
7.2 Abcam PLC
7.2.1 Abcam PLC Company Summary
7.2.2 Abcam PLC Business Overview
7.2.3 Abcam PLC Recombinant Proteins Major Product Offerings
7.2.4 Abcam PLC Recombinant Proteins Revenue in Global Market (2018-2023)
7.2.5 Abcam PLC Key News & Latest Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Company Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Recombinant Proteins Major Product Offerings
7.3.4 Merck KGaA Recombinant Proteins Revenue in Global Market (2018-2023)
7.3.5 Merck KGaA Key News & Latest Developments
7.4 Miltenyi Biotec
7.4.1 Miltenyi Biotec Company Summary
7.4.2 Miltenyi Biotec Business Overview
7.4.3 Miltenyi Biotec Recombinant Proteins Major Product Offerings
7.4.4 Miltenyi Biotec Recombinant Proteins Revenue in Global Market (2018-2023)
7.4.5 Miltenyi Biotec Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Recombinant Proteins Major Product Offerings
7.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue in Global Market (2018-2023)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 ACROBiosystems
7.6.1 ACROBiosystems Company Summary
7.6.2 ACROBiosystems Business Overview
7.6.3 ACROBiosystems Recombinant Proteins Major Product Offerings
7.6.4 ACROBiosystems Recombinant Proteins Revenue in Global Market (2018-2023)
7.6.5 ACROBiosystems Key News & Latest Developments
7.7 Sino Biological
7.7.1 Sino Biological Company Summary
7.7.2 Sino Biological Business Overview
7.7.3 Sino Biological Recombinant Proteins Major Product Offerings
7.7.4 Sino Biological Recombinant Proteins Revenue in Global Market (2018-2023)
7.7.5 Sino Biological Key News & Latest Developments
7.8 Cytiva
7.8.1 Cytiva Company Summary
7.8.2 Cytiva Business Overview
7.8.3 Cytiva Recombinant Proteins Major Product Offerings
7.8.4 Cytiva Recombinant Proteins Revenue in Global Market (2018-2023)
7.8.5 Cytiva Key News & Latest Developments
7.9 Eurogentec
7.9.1 Eurogentec Company Summary
7.9.2 Eurogentec Business Overview
7.9.3 Eurogentec Recombinant Proteins Major Product Offerings
7.9.4 Eurogentec Recombinant Proteins Revenue in Global Market (2018-2023)
7.9.5 Eurogentec Key News & Latest Developments
7.10 GenScript Biotech Corporation
7.10.1 GenScript Biotech Corporation Company Summary
7.10.2 GenScript Biotech Corporation Business Overview
7.10.3 GenScript Biotech Corporation Recombinant Proteins Major Product Offerings
7.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue in Global Market (2018-2023)
7.10.5 GenScript Biotech Corporation Key News & Latest Developments
7.11 Reprocell
7.11.1 Reprocell Company Summary
7.11.2 Reprocell Business Overview
7.11.3 Reprocell Recombinant Proteins Major Product Offerings
7.11.4 Reprocell Recombinant Proteins Revenue in Global Market (2018-2023)
7.11.5 Reprocell Key News & Latest Developments
7.12 BPS Bioscience
7.12.1 BPS Bioscience Company Summary
7.12.2 BPS Bioscience Business Overview
7.12.3 BPS Bioscience Recombinant Proteins Major Product Offerings
7.12.4 BPS Bioscience Recombinant Proteins Revenue in Global Market (2018-2023)
7.12.5 BPS Bioscience Key News & Latest Developments
7.13 Abnova Corporation
7.13.1 Abnova Corporation Company Summary
7.13.2 Abnova Corporation Business Overview
7.13.3 Abnova Corporation Recombinant Proteins Major Product Offerings
7.13.4 Abnova Corporation Recombinant Proteins Revenue in Global Market (2018-2023)
7.13.5 Abnova Corporation Key News & Latest Developments
7.14 ProSpec Tany TechnoGene
7.14.1 ProSpec Tany TechnoGene Company Summary
7.14.2 ProSpec Tany TechnoGene Business Overview
7.14.3 ProSpec Tany TechnoGene Recombinant Proteins Major Product Offerings
7.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue in Global Market (2018-2023)
7.14.5 ProSpec Tany TechnoGene Key News & Latest Developments
7.15 Ajinomoto
7.15.1 Ajinomoto Company Summary
7.15.2 Ajinomoto Business Overview
7.15.3 Ajinomoto Recombinant Proteins Major Product Offerings
7.15.4 Ajinomoto Recombinant Proteins Revenue in Global Market (2018-2023)
7.15.5 Ajinomoto Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report